| CAS No. | CATO-C4X-2007170 |
| Molecular Formula | C10H19BrO2 |
| Molecular Weight | 251.16 g/mol |
| Category | Pharmacopoeial Impurity Standards / EP Impurities |
| Availability | In Stock |
Owing to a carboxylic acid group, a hydroxyl group, an ether linkage, bromine substitution, Brivaracetam Impurity 170 is typically white to off-white crystalline powder. Its solid-state physicochemical attributes — including a molecular weight of 251.16 g/mol — guide the selection of appropriate sample preparation and analytical techniques. Halogen substitution (F/Cl/Br/I) produces a distinctive isotope pattern in mass spectrometry, a valuable aid for qualitative confirmation.
Brivaracetam Impurity 170 (CAS CATO-C4X-2007170) is a certified pharmaceutical impurity reference standard with the molecular formula C10H19BrO2 and a molecular weight of 251.16 g/mol.
This reference standard supports related-substances testing and method development in line with ICH Q3A/Q3B guidance on impurity control, and is suitable for system suitability testing and forced-degradation studies.
The assigned purity is verified by mass-balance and quantitative NMR (qNMR) approaches, with the expanded uncertainty reported at a 95% confidence level (k=2). Batch homogeneity and stability are independently assessed for every lot.
| Molecular Formula | C10H19BrO2 |
| Molecular Weight | 251.16 g/mol |
| Purity | ≥95% |
| Storage | Store at room temperature, keep tightly closed to prevent evaporation |
| Solubility (reference) | Soluble in chloroform, dichloromethane, ethyl acetate, DMSO |
| Stability | Contains ester bond; hydrolyzes under strong alkaline conditions |
| Degree of Unsaturation (DBE) | 1.0 |
| Halogen Content | Br-containing |